Illustration(s) pertain to the topic addressed in this publication, not the specific research or data presented in the publication

Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring


The World Health Organization recommends Mycobacterium bovis BCG vaccination in areas of high tuberculosis prevalence. BCG’s clinical and immune effects, not necessarily Mycobacterium tuberculosis specific, are unclear. BCG vaccine scarring often is used as a surrogate marker of vaccination or of effective vaccination.… Read more